TrialBMC infectious diseases2014

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial.

Jose Vazquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.